Cellectis
CLLS
40 hedge funds and large institutions have $238M invested in Cellectis in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 17 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 6
12% more capital invested
Capital invested by funds: $213M → $238M (+$25.6M)
9% less funds holding
Funds holding: 44 → 40 (-4)
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$6.74M |
| 2 |
PA
Perceptive Advisors
New York
|
+$6.32M |
| 3 |
GL
GLG LLC
New York
|
+$6.24M |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$4.99M |
| 5 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$4.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$10.4M |
| 2 |
DM
Deerfield Management
New York
|
-$5.2M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$2.59M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.25M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.89M |
CLLS Hedge Fund Activity: Q2 2015 in Review
40 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q2 2015, worth a combined $238M — up 12% from $213M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of CLLS and 13 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 14 added.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $6.74M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $10.4M sold.
- 40 institutional investors held Cellectis (CLLS) as of Q2 2015, down from 44 in Q1 2015.
- Funds reported $238M of Cellectis stock for Q2 2015, up 12% quarter-over-quarter.
- 13 funds opened new Cellectis positions in Q2 2015 and 17 closed out, a net change of -4 holders.
- The largest Cellectis buyer in Q2 2015 was Hudson Bay Capital Management, an estimated $6.74M added.
- The largest Cellectis seller in Q2 2015 was T. Rowe Price Associates, an estimated $10.4M sold.
Based on aggregated 13F filings for Q2 2015.